Cingulate Inc. (CING) Stock Analysis — Probabli.AI
AI-powered analysis for CING (Cingulate Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $4.88 · Market cap: $64.4M · AI outlook: Bullish
Cingulate Inc., with its small market cap and innovative pipeline, shows immense growth potential driven by ADHD treatments. Analysts are highly optimistic, projecting valuations many multiples of the current share price. However, risks related to execution, competition, and patents warrant some caution. In the short-term, sporadic financial performance and reliance on breakthrough approval…
Probabilistic 1-Year Outlook
- Bull 40% · Neutral 35% · Bear 25%
- 1-year price estimates — P10: $4 / P50: $7 / P90: $12
- With Cingulate Inc.'s strong analyst recommendations and potential for pipeline success, the bullish case has a higher probability relative to the bearish scenario. However, risks such as competition in the ADHD space…
5-Year Outlook
- Bull 50% · Neutral 30% · Bear 20%
- 5-year price estimates — P10: $5 / P50: $15 / P90: $40
SWOT Highlights
- Strength: Strong pipeline in ADHD treatments
- Strength: Positive investor sentiment supported by recent earnings beat
- Risk: Small market cap with limited financial buffer
- Risk: Average EPS surprises indicating inconsistent performance
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
2 Wall Street analysts rate CING a STRONG BUY with a mean price target of $34.5.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
CING forecast details · CING sentiment details · CING insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.